Cadrenal Therapeutics
CVKD
#9734
Rank
HK$0.25 B
Marketcap
HK$130.31
Share price
-1.18%
Change (1 day)
161.76%
Change (1 year)

EPS for Cadrenal Therapeutics (CVKD)

EPS in 2024 (TTM): -HK$54.17

According to Cadrenal Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$53.83. In 2023 the company made an earnings per share (EPS) of -HK$72.06.

EPS history for Cadrenal Therapeutics from 2023 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-HK$54.17-24.83%
2023-HK$72.06